NCT04308811View on ClinicalTrials.gov

Autologous Platelet-Rich Plasma in the Management of Asherman Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 10, 2019

Primary Completion Date

February 20, 2020

Study Completion Date

February 20, 2020

Conditions
Intrauterine Adhesion
Interventions
BIOLOGICAL

platelet rich plasma

Platelet rich plasma and intrauterine balloon applied intrauterine after hysteroscopic adhesiolysis of intrauterine adhesions

COMBINATION_PRODUCT

amniotic membrane graft group

amniotic membrane applied on the intrauterine balloon after hysteroscopic lysis of intrauterine adhesions

DEVICE

Intrauterine balloon

intrauterine balloon applied intrauterine after hysteroscopic lysis of intrauterine adhesions

Trial Locations (1)

Unknown

Endoscopy unit, Ain shams university Maternity hospital, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT04308811 - Autologous Platelet-Rich Plasma in the Management of Asherman Syndrome | Biotech Hunter | Biotech Hunter